Dyne Therapeutics, Inc.DYNNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank15
Studio
Year-over-Year Change

Year-over-year revenue growth rate

Latest
0.00%
↓ 100% vs avg
Percentile
P15
Within normal range
Average
7.67%
Historical baseline
PeriodValue
Q4 20250.00%
Q3 20250.00%
Q2 20250.00%
Q1 20250.00%
Q4 20240.00%
Q3 20240.00%
Q2 20240.00%
Q1 20240.00%
Q4 20230.00%
Q3 20230.00%
Q2 20230.00%
Q1 20230.00%
Q4 20220.00%
Q3 20220.00%
Q2 20220.00%
Q1 20220.00%
Q4 20210.00%
Q3 20210.00%
Q2 20210.00%
Q1 20210.00%
Q4 20200.00%
Q3 20200.00%
Q2 20200.00%
Q1 20200.00%
Q4 20190.00%
Q3 20190.00%
Q2 20190.00%
Q1 20190.00%
Q4 2017158.24%
Q3 20170.55%
Q2 20173.43%
Q1 2017-77.88%
Q4 2016228.22%
Q3 201645.18%
Q2 2016-1.19%
Q1 2016-22.58%
Q4 2015-65.28%
Q3 2015-61.47%
Q2 2015156.65%
Q1 2015-56.89%